Guangdong Kanghua Healthcare Co., Ltd. (3689.HK)
HKD 2.16
(-1.37%)
HKD 2.16
(-1.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.04 Billion | 1.84 Billion | 1.95 Billion | 1.74 Billion | 1.95 Billion | 1.63 Billion |
| Cost of Revenue | 1.67 Billion | 1.58 Billion | 1.6 Billion | 1.48 Billion | 1.56 Billion | 1.28 Billion |
| Gross Profit | 364.37 Million | 261.35 Million | 352.74 Million | 263.15 Million | 389.41 Million | 358.9 Million |
| Operating Expenses | 225.68 Million | 222.59 Million | 214.03 Million | 221.42 Million | 232.13 Million | 187.19 Million |
| Selling, General and Administrative Expenses | 242.39 Million | 228.32 Million | 225.22 Million | 227.77 Million | 232.28 Million | 185.17 Million |
| Research and Development Expenses | - | 1.09 Million | 835 Thousand | 1.59 Million | 1.03 Million | 620 Thousand |
| Other Expenses | - | -5.73 Million | -11.18 Million | -6.34 Million | -143 Thousand | 13.24 Million |
| Cost and Expenses | 1.92 Billion | 1.8 Billion | 1.81 Billion | 1.7 Billion | 1.79 Billion | 1.46 Billion |
| Operating Income | 119.21 Million | 73.11 Million | 139.74 Million | -22.16 Million | 113.77 Million | 171.7 Million |
| Interest Expense | 12.05 Million | 15.04 Million | 19.81 Million | 21.99 Million | 17.24 Million | 936 Thousand |
| Income Tax Expense | 62.4 Million | 41.57 Million | 62.28 Million | 23.96 Million | 68.79 Million | 60.48 Million |
| Earnings before Tax | 153.42 Million | 69.3 Million | 129.2 Million | -26.08 Million | 117.48 Million | 221.75 Million |
| Net Income | 121.06 Million | 27.73 Million | 66.92 Million | -50.05 Million | 48.68 Million | 167.94 Million |
| Earnings Per Share Basic | 0.36 | 0.08 | 0.20 | -0.15 | 0.15 | 0.50 |
| Earnings Per Share Diluted | 0.36 | 0.08 | 0.20 | -0.15 | 0.15 | 0.50 |
| Weighted Average Shares Outstanding | 334.39 Million | 334.39 Million | 334.39 Million | 333.84 Million | 334.39 Million | 334.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 334.39 Million | 334.39 Million | 334.39 Million | 334.39 Million | 334.39 Million | 334.39 Million |
| Gross Margin | 0.18 | 0.14 | 0.18 | 0.15 | 0.20 | 0.22 |
| EBIT Margin | 0.15 | 0.12 | 0.15 | 0.07 | 0.12 | 0.16 |
| Profit Margin | 0.06 | 0.02 | 0.03 | -0.03 | 0.02 | 0.10 |
| EBITDA | 308.56 Million | 233.79 Million | 298.46 Million | 138.79 Million | 257.33 Million | 269.74 Million |
| Earnings Before Tax Margin | 0.06 | 0.04 | 0.07 | -0.01 | 0.06 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 492.25 Million | 492.25 Million | 527.17 Million | 2.04 Billion | 527.17 Million | 493.74 Million |
| Cost of Revenue | 419.05 Million | 419.05 Million | 440.49 Million | 1.67 Billion | 440.49 Million | 408.25 Million |
| Gross Profit | 73.19 Million | 73.19 Million | 86.68 Million | 364.37 Million | 86.68 Million | 85.49 Million |
| Operating Expenses | 72.03 Million | 72.03 Million | 48.78 Million | 240.11 Million | 41.19 Million | 56.75 Million |
| Selling, General and Administrative Expenses | 71.85 Million | 71.85 Million | 48.62 Million | - | 48.62 Million | 63.92 Million |
| Research and Development Expenses | 180.5 Thousand | 180.5 Thousand | 165.5 Thousand | - | 165.5 Thousand | 129 Thousand |
| Other Expenses | - | - | - | 26.99 Million | - | - |
| Cost and Expenses | 491.09 Million | 491.09 Million | 489.28 Million | 1.91 Billion | 481.68 Million | 465 Million |
| Operating Income | 1.16 Million | 1.16 Million | 37.89 Million | 119.21 Million | 38.06 Million | 21.57 Million |
| Interest Expense | - | - | - | 12.05 Million | - | 7.19 Million |
| Income Tax Expense | 10.77 Million | 10.77 Million | 16.34 Million | 62.4 Million | 16.34 Million | 14.85 Million |
| Earnings before Tax | -1.55 Million | -1.55 Million | 47.17 Million | 153.42 Million | 47.17 Million | 29.54 Million |
| Net Income | -9.77 Million | -9.77 Million | 35.2 Million | 121.06 Million | 35.2 Million | 25.32 Million |
| Earnings Per Share Basic | -0.03 | -0.03 | 0.11 | - | 0.11 | 0.08 |
| Earnings Per Share Diluted | -0.03 | -0.03 | 0.11 | - | 0.11 | 0.08 |
| Weighted Average Shares Outstanding | 334.39 Million | 334.39 Million | 334.39 Million | 334.39 Million | 334.39 Million | 335.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 334.39 Million | 334.39 Million | 334.39 Million | 334.39 Million | 334.39 Million | 334.39 Million |
| Gross Margin | 0.15 | 0.15 | 0.16 | 0.18 | 0.16 | 0.17 |
| EBIT Margin | 0.06 | 0.06 | 0.12 | - | 0.12 | 0.10 |
| Profit Margin | -0.02 | -0.02 | 0.07 | 0.06 | 0.07 | 0.05 |
| EBITDA | 28.24 Million | 28.24 Million | 64.59 Million | - | 64.59 Million | 48.99 Million |
| Earnings Before Tax Margin | 0.00 | 0.00 | 0.07 | 0.06 | 0.07 | 0.04 |
DASTF
002189
SIGC
000564
EKAD
LEMONTREE